Evidence map›Paper›PMID 32503975›Full record

ArticleLeukemia2020

Prediction of immunomodulatory drugs (IMiDs) sensitivity in myeloma via determination of baseline anti-oxidative stress capacity.

Luke Mountjoy, Sinto Sebastian, Tania Jain, Talal Hilal, Miguel Gonzalez-Velez, Marlene Girardo, Greg Ahmann, Jeremy Larsen, Leif Bergsagel, Rafael Fonseca

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Luke MountjoyDivision of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
Sinto SebastianDivision of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
Tania JainHematologic Malignancies and Bone Marrow Transplantation Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6854-773X
Talal HilalDivision of Hematology and Medical Oncology, University of Mississippi Medical Center, Jackson, MS, USA.ORCID http://orcid.org/0000-0001-8249-4128
Miguel Gonzalez-VelezDivision of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0001-9914-8459
Marlene GirardoDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Phoenix, AZ, USA.
Greg AhmannDivision of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
Jeremy LarsenDivision of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
Leif BergsagelDivision of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0003-1523-7388
Rafael FonsecaDivision of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA. fonseca.rafael@mayo.edu.ORCID http://orcid.org/0000-0002-5938-3769

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsAntioxidantsBone Marrow CellsDrug Resistance, NeoplasmFemaleHumansImmunologic FactorsImmunophenotypingMaleMiddle AgedMultiple MyelomaOxidation-ReductionOxidative StressAntineoplastic AgentsAntioxidantsImmunologic Factors

Identifiers

PMID32503975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.